The Beauty Health Company (SKIN) Tops Q4 EPS by 3c

The Beauty Health Company (NASDAQ: SKIN) reported Q4 EPS of ($0.08), $0.03 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $83.5 million versus the consensus estimate of $77.39 million.

For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.

You May Also Be Interested In

• KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
• Evercore ISI Starts Permian Resources Corp (PR) at Outperform
• Evercore ISI Downgrades Darden Restaurants (DRI) to In Line